
Advanced Transplant Diagnostics And Immunogenetics Private Limited
Founded in 2019 and headquartered in Maharashtra, India.
Founded in 2019 and headquartered in Maharashtra, India.
Advanced Transplant Diagnostics And Immunogenetics Private Limited (ATDAIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 September 2019 (Five years and seven months 2 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Shah, Shruti Tapiawala, Hepal Vora, and Two other members serve as directors at the Company.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U93090MH2019PTC330328
330328
Private Limited Indian Non-Government Company
09 Sep 2019
26 Jun 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shruti Tapiawala ![]() | Director | 09-Sep-2019 | Current |
Bharat Shah ![]() | Director | 09-Sep-2019 | Current |
Hepal Vora ![]() | Director | 06-Nov-2020 | Current |
Zaheer Virani ![]() | Director | 06-Nov-2020 | Current |
Prashant Rajput ![]() | Director | 06-Nov-2020 | Current |
Advanced Transplant Diagnostics And Immunogenetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.83% increase. The company also saw a substantial fall in profitability, with a 35.08% decrease in profit. The company's net worth Soared by an impressive increase of 58.27%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Advanced Transplant Diagnostics And Immunogenetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Bharat Shah is a mutual person
Bharat Shah, Shruti Tapiawala and 3 more are mutual person
Bharat Shah, Shruti Tapiawala and 3 more are mutual person
Prashant Rajput is a mutual person
Prashant Rajput is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Advanced Transplant Diagnostics And Immunogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Advanced Transplant Diagnostics And Immunogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transplant Diagnostics And Immunogenetics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Advanced Transplant Diagnostics And Immunogenetics Private Limited last Annual general meeting of members was held on 26 Jun 2024 as per latest MCA records.
Advanced Transplant Diagnostics And Immunogenetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Hepal Mihir Vora was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 4 years 5 months .
Zaheer Aminmohamed Virani was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 4 years 5 months .
Prashant Jayendrasingh Rajput was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 4 years 5 months .
Bharat Vallabhdas Shah was appointed as a Director was appointed as a Director on 09 Sep 2019 & has been associated with this company since 5 years 7 months .
Advanced Transplant Diagnostics And Immunogenetics Private Limited was incorporated on 09 Sep 2019.
The authorized share capital of Advanced Transplant Diagnostics And Immunogenetics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 5 directors are associated with Advanced Transplant Diagnostics And Immunogenetics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Advanced Transplant Diagnostics And Immunogenetics Private Limited is 401 Rajveer Royals Next To Jyoti Dwelling Bld Ghatkopar Andheri Link Rd Chakala, E Mumbai India, Chakala Andheri E Mumbai, Maharashtra, 400093.
The corporate identification number (CIN) of Advanced Transplant Diagnostics And Immunogenetics Private Limited is U93090MH2019PTC330328 and the company number is 330328 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Advanced Transplant Diagnostics And Immunogenetics Private Limited has risen by 63.83%.
The financial reports for the fiscal year 2023 indicates that The net worth of Advanced Transplant Diagnostics And Immunogenetics Private Limited has experienced an upsurge of 58.27%.
The most recent Balance Sheet for Advanced Transplant Diagnostics And Immunogenetics Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.